Analgesics in Pakistan
In January 2019, the Drug Regulatory Authority of Pakistan (DRAP) notified a 15% increase in the retail price of medicines (9% on lifesaving drugs). The price rise came as a result of the weakening of the Pakistan rupee against the dollar, partly in anticipation of a devaluation of the currency as part of an IMF bailout deal, and the resultant increase in raw material and packaging material costs, as well as an increase in electricity and gas tariffs. Nonetheless, the DRAP is expected to work to...
Euromonitor International's Analgesics in Pakistan report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2014-2018, allowing you to identify the sectors driving growth. Forecasts to 2023 illustrate how the market is set to change.
Product coverage: Systemic Analgesics, Topical Analgesics/Anaesthetic.
Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.
Why buy this report?
* Get a detailed picture of the Analgesics market;
* Pinpoint growth sectors and identify factors driving change;
* Understand the competitive environment, the market’s major players and leading brands;
* Use five-year forecasts to assess how the market is predicted to develop.
Euromonitor International has over 40 years' experience of publishing market research reports, business reference books and online information systems. With offices in London, Chicago, Singapore, Shanghai, Vilnius, Dubai, Cape Town, Santiago, Sydney, Tokyo and Bangalore and a network of over 800 analysts worldwide, Euromonitor International has a unique capability to develop reliable information resources to help drive informed strategic planning.
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.Download eBook